Loading clinical trials...
Loading clinical trials...
EVALUATION OF THE SAFETY AND EFFICACY OF REBORN LED SYSTEM FOR NON-INVASIVE LIPOLYSIS TREATMENT
Conditions
Interventions
reborn treatment
Locations
3
United States
Tennessee Clinical Research Center
Tennessee City, Tennessee, United States
Herzelia Medical Center - Tal Nachliely clinic
Kiryat Bialik, Israel
rabin medical center - campus Hasharon
Petah Tikva, Israel
Start Date
June 30, 2022
Primary Completion Date
November 11, 2023
Completion Date
November 11, 2023
Last Updated
February 15, 2024
Lead Sponsor
Lightfective Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions